APA (7th ed.) Citation

LJ, W., P, Z., GL, W., SC, C., WY, C., JC, H., . . . Y, Z. (2026). Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease. Frontiers in medicine, 13, 1743905. https://doi.org/10.3389/fmed.2026.1743905

Chicago Style (17th ed.) Citation

LJ, Wang, Zhang P, Wang GL, Chen SC, Cao WY, Han JC, Sun JG, Feng JC, and Zheng Y. "Schisandra Chinensis Fructus and Its Active Metabolites for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease." Frontiers in Medicine 13 (2026): 1743905. https://doi.org/10.3389/fmed.2026.1743905.

MLA (9th ed.) Citation

LJ, Wang, et al. "Schisandra Chinensis Fructus and Its Active Metabolites for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease." Frontiers in Medicine, vol. 13, 2026, p. 1743905, https://doi.org/10.3389/fmed.2026.1743905.